Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Zash

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Open Forum Infectious Diseases|August 12, 2021
The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in BotswanaChristina Fennell, Modeigi Diseko, Rebecca Zash, et al.
The Lancet. Global Health|May 13, 2022
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in BotswanaEllen C Caniglia, Rebecca Zash, Sonja A Swanson, et al.
Epidemiology (Cambridge, Mass.)|February 22, 2023
Emulating Target Trials to Avoid Immortal Time Bias - An Application to Antibiotic Initiation and Preterm DeliveryEllen C Caniglia, Rebecca Zash, Christina Fennell, et al.
Paediatric and Perinatal Epidemiology|October 22, 2025
Safety of Antihypertensive Medication for the Management of Non-Severe Gestational Hypertension Among Pregnant Individuals in Botswana-Emulating a Series of Target TrialsJulia D DiTosto, Rebecca Zash, Denise L Jacobson, et al.
American Journal of Obstetrics and Gynecology|December 21, 2020
Modest reduction in adverse birth outcomes following the COVID-19 lockdownEllen C Caniglia, Lerato E Magosi, Rebecca Zash, et al.
Plos One|September 25, 2024
No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron eraJaspreet Banga, Maya Jackson-Gibson, Modiegi Diseko, et al.
The New England Journal of Medicine|July 23, 2019
Neural-Tube Defects and Antiretroviral Treatment Regimens in BotswanaRebecca Zash, Lewis Holmes, Modiegi Diseko, et al.
Eclinicalmedicine|December 9, 2020
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysisSteve Kanters, Marco Vitoria, Michael Zoratti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 21, 2020
Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in BotswanaSonya Davey, Gbolahan Ajibola, Kenneth Maswabi, et al.
Obstetrics and Gynecology|January 26, 2023
Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus StatusMaya Jackson-Gibson, Modiegi Diseko, Ellen C Caniglia, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Open Forum Infectious Diseases|August 12, 2021
The Impact of Syndromic Management of Vaginal Discharge Syndrome on Adverse Birth Outcomes in BotswanaChristina Fennell, Modeigi Diseko, Rebecca Zash, et al.
The Lancet. Global Health|May 13, 2022
Iron, folic acid, and multiple micronutrient supplementation strategies during pregnancy and adverse birth outcomes in BotswanaEllen C Caniglia, Rebecca Zash, Sonja A Swanson, et al.
Epidemiology (Cambridge, Mass.)|February 22, 2023
Emulating Target Trials to Avoid Immortal Time Bias - An Application to Antibiotic Initiation and Preterm DeliveryEllen C Caniglia, Rebecca Zash, Christina Fennell, et al.
Paediatric and Perinatal Epidemiology|October 22, 2025
Safety of Antihypertensive Medication for the Management of Non-Severe Gestational Hypertension Among Pregnant Individuals in Botswana-Emulating a Series of Target TrialsJulia D DiTosto, Rebecca Zash, Denise L Jacobson, et al.
American Journal of Obstetrics and Gynecology|December 21, 2020
Modest reduction in adverse birth outcomes following the COVID-19 lockdownEllen C Caniglia, Lerato E Magosi, Rebecca Zash, et al.
Plos One|September 25, 2024
No impact of COVID-19 at delivery on maternal mortality or infant adverse birth outcomes in Botswana during the Omicron eraJaspreet Banga, Maya Jackson-Gibson, Modiegi Diseko, et al.
The New England Journal of Medicine|July 23, 2019
Neural-Tube Defects and Antiretroviral Treatment Regimens in BotswanaRebecca Zash, Lewis Holmes, Modiegi Diseko, et al.
Eclinicalmedicine|December 9, 2020
Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysisSteve Kanters, Marco Vitoria, Michael Zoratti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 21, 2020
Mother-to-Child HIV Transmission With In Utero Dolutegravir vs. Efavirenz in BotswanaSonya Davey, Gbolahan Ajibola, Kenneth Maswabi, et al.
Obstetrics and Gynecology|January 26, 2023
Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus StatusMaya Jackson-Gibson, Modiegi Diseko, Ellen C Caniglia, et al.
Pageof 7